Impact of Adding Concomitant Chemotherapy to Hyperfractionated Accelerated Radiotherapy for Advanced Head-and-Neck Squamous Cell Carcinoma
Sandra Nuyts(Cancer Institute (WIA)), Walter Van den Bogaert(Radboud University Nijmegen), Piet Dirix(Iridium Kankernetwerk), Paul M. Clément(Universitair Ziekenhuis Leuven), Robert Hermans(Universitair Ziekenhuis Leuven), Joseph Schoenaers(KU Leuven), Pierre Delaere, Vincent Vander Poorten(KU Leuven)
International Journal of Radiation Oncology*Biology*Physics
August 16, 2008
Cited by 72
Related Papers
Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial
|Journal of Clinical Oncology|2007|1k
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
|New England Journal of Medicine|2015|1k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
|New England Journal of Medicine|2001|950
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
|Journal of Clinical Oncology|2009|573